Deutsche Bank Aktiengesellschaft Boosts UnitedHealth Group (NYSE:UNH) Price Target to $625.00

UnitedHealth Group (NYSE:UNH) had its price target lifted by research analysts at Deutsche Bank Aktiengesellschaft from $595.00 to $625.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the healthcare conglomerate’s stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 2.71% from the stock’s previous close.

Other equities analysts have also recently issued research reports about the company. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. UBS Group dropped their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Truist Financial restated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, TD Cowen boosted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $621.58.

UnitedHealth Group Trading Down 0.3 %

Shares of UNH stock opened at $608.52 on Tuesday. The company has a market cap of $560.01 billion, a PE ratio of 39.64, a price-to-earnings-growth ratio of 1.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s 50 day simple moving average is $585.43 and its two-hundred day simple moving average is $556.65.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the business earned $6.56 earnings per share. Research analysts predict that UnitedHealth Group will post 27.6 earnings per share for the current year.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. International Assets Investment Management LLC grew its position in shares of UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth $480,903,000. Dimensional Fund Advisors LP boosted its holdings in shares of UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. Baillie Gifford & Co. increased its position in shares of UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after acquiring an additional 821,050 shares in the last quarter. Finally, Accredited Investors Inc. increased its holdings in UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after acquiring an additional 776,516 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.